期刊文献+

原发性肝癌的治疗选择:切除?消融?介入?移植? 被引量:13

Treatment options for hepatocellular carcinoma: surgical resection,locoregional ablation,interventional therapy or liver transplantation?
原文传递
导出
摘要 肝癌手术切除、局部消融、介入治疗和肝移植术是当前肝癌的主要治疗手段,但这四种方法的适应证有部分重叠,且综合应用时的实施次序有较大争议。如何确定最佳的个体化综合治疗方案,是普通外科医师面临的一个巨大挑战。 Nowadays, the treatment of hepatocellular carcinoma (HCC) mainly includes surgical resection, locoregional ablation, interventional therapy and liver transplantation. The indications of the four methods overlap partly, and there are some controversial viewpoints about the order of the methods' application. It' s still a considerable challenge for surgeons to optimize personalized muhimodality treatments for HCC.
作者 窦科峰 李霄
出处 《中国实用外科杂志》 CSCD 北大核心 2010年第8期633-637,共5页 Chinese Journal of Practical Surgery
关键词 原发性肝癌 外科切除 局部消融 介入治疗 肝移植 primary liver carcinoma surgical resection locoregional ablation interventional therapy liver transplantation
  • 相关文献

参考文献3

二级参考文献104

  • 1Parkin DM,Bray F,Ferlay J,Pisani P.Estimating the world cancer burden:Globocan 2000.Int J Cancer 2001; 94:153-156.
  • 2Befeler AS,Di Bisceglie AM.Hepatocellular carcinoma:diagnosis and treatment.Gastroenterology 2002; 122:1609-1619.
  • 3Liu JH,Chen PW,Asch SM,Busuttil RW,Ko CY.Surgery for hepatocellular carcinoma:does it improve survival? Ann Surg Oncol 2004; 11:298-303.
  • 4Fong TL,Kanel GC,Conrad A,Valinluck B,Charboneau F,Adkins RH.Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease.Hepatology 1994; 19:554-557.
  • 5Ming L,Thorgeirsson SS,Gail MH,Lu P,Harris CC,Wang N,Shao Y,Wu Z,Liu G,Wang X,Sun Z.Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong,China.Hepatology 2002; 36:1214-1220.
  • 6Hassan MM,Hwang LY,Hatten CJ,Swaim M,Li D,Abbruzzese JL,Beasley P,Patt YZ.Risk factors for hepatocellular carcinoma:synergism of alcohol with viral hepatitis and diabetes mellitus.Hepatology 2002; 36:1206-1213.
  • 7Ohata K,Hamasaki K,Toriyama K,Matsumoto K,Saeki A,Yanagi K,Abiru S,Nakagawa Y,Shigeno M,Miyazoe S,Ichikawa T,Ishikawa H,Nakao K,Eguchi K.Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection.Cancer 2003; 97:3036-3043.
  • 8El-Serag HB,Richardson PA,Everhart JE.The role of diabetes in hepatocellular carcinoma:a case-control study among United States Veterans.Am J Gastroenterol 2001; 96:2462-2467.
  • 9Davila JA,Morgan RO,Shaib Y,McGlynn KA,El-Serag HB.Diabetes increases the risk of hepatocellular carcinoma in the United States:a population based case control study.Gut 2005; 54:533-539.
  • 10Chokshi MM,Marrero JA.Hepatocellular carcinoma.Curr Opin Gastroenterol 2001; 17:276-280.

共引文献68

同被引文献77

引证文献13

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部